Oscar Lopez, MD, FAAN, discusses the new treatments for Alzheimer’s disease.
Upon completion of this activity, participants should be able to:
- Explain the outcomes of new treatments for Alzheimer’s disease
- Describe the role of peripheral biomarkers
- Identify current prevention treatments of Alzheimer’s disease
All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships for the individuals listed below have been mitigated
- Consultant: Grifols, Biogen
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
For your credit transcript, please access our website four weeks postcompletion at http://ccehs.upmc.com and follow the link to the Credit Transcript page.
Release Date: 4/20/2021 | Last Modified On: 7/8/2022 | Expires: 7/8/2023